Point72 Asia (Singapore) Pte. Ltd. Vigil Neuroscience, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $379 Billion
- Q4 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 10,836 shares of VIGL stock, worth $26,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,836
Previous 11,687
7.28%
Holding current value
$26,223
Previous $39.7 Million
53.64%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding VIGL
# of Institutions
53Shares Held
26.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$14.1 Million1.62% of portfolio
-
Northpond Ventures, LLC4.21MShares$10.2 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$4.82 Million0.15% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$4.39 Million0.11% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.51MShares$3.65 Million0.0% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $68.4M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...